Review articleMalondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
References (196)
Mechanisms of lipid peroxidation
Free Radic. Biol. Med.
(1985)On the detection of lipid hydroperoxides in biological samples
Free Radic. Biol. Med.
(1989)- et al.
Studies on the reactivity of malondialdehyde. I. Effects of acid concentration and solvent composition on deuterium exchange reactions
Chem. Phys. Lipids
(1983) The use of standards for malonydialdehyde
Anal. Biochem.
(1975)- et al.
A sensitive colorimetric method for the estimation of 2-deoxy sugars with the use of the malonaldehyde-thiobarbituric acid reaction
J. Biol. Chem.
(1959) - et al.
Liquid chromatographic determination of serum lipid peroxides as diphenylthio-barbituric acid-reactive substance to collagen disease patients—a preliminary study
J. Chromatogr.
(1987) Fluorescent products derived from the reaction of primary amines and components in peroxidized lipids
Adv. Free Radic. Biol. Med.
(1986)- et al.
Determination of malonaldehyde in oxidized lipids by the Hantzsch fluorometric method
Anal. Biochem.
(1988) - et al.
High performance liquid chromatographic determination of malonaldehyde in serum
J. Chromatogr.
(1989) - et al.
Subpicogram determination of malondialdehyde by gas-liquid chromatography with nitrogen phosphorus detector
Anal. Biochem.
(1988)
Determination of free malonaldehyde by gas chromatography with an electron-capture detector
J. Chromatogr.
Recovery of malondialdehyde in urine as a 2,4-dinitrophenylhydrazine derivative analyzed with high-performance liquid chromatography
Chem. Biol. Interact.
Identification of N-(2-propenal)-ethanolamine as a urinary metabolite of malondialdehyde
Free Radic. Biol. Med.
Distribution and oxidation of malondialdehyde in mice
Prostaglandins
Mechanism of horseradish peroxidase-catalyzed oxidation of malonaldehyde
Arch. Biochem. Biophys.
Thiobarbituric acid-reactivity following iron-dependent free radical damage to amino acids and carbohydrates
FEBS Lett.
The thiobarbituric acid-reactivity of bile pigments
Biochem. Med.
Identification of malondialdehyde as the TBA-reactant formed by bleomycin-iron-radical damage to DNA
FEBS Lett.
Origin of malondialdehyde from DNA degraded by Fe(II) bleomycin
J. Biol. Chem.
A method of estimation of 2-deoxyribose
Biochim. Biophys. Acta
A sensitive colorimetric method for the estimation of 2-deoxysugars with the use of the malonaldehyde-thiobarbituric acid reaction
J. Biol. Chem.
The formation of malonaldehyde in irradiated carbohydrates
Carbohydr. Res.
Products, kinetics, and substrate specificity of homogenous thromboxane synthetase from human platelets: development of a novel enzyme assay
Arch. Biochem. Biophys.
Transition metals as catalysts of “autoxidation” reactions
Free Radic. Biol. Med.
Oxygen radical chemistry of polyunsaturated fatty acids
Free Radic. Biol. Med.
Methods for the determination of aldehydic lipid peroxidation products
Free Radic. Biol. Med.
Chemistry of lipid peroxidation
Methods Enzymol.
The thiobarbituric acid reaction and the autoxidation of polyunsaturated fatty acid methyl esters
Arch. Biochem. Biophys.
Formation of malonaldehyde from lipid oxidation products
Biochim. Biophys. Acta
Autoxidation of human low-density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
J. Lipid Res.
Detection of malonaldehyde by high-performance liquid chromatography
Methods Enzymol.
Free malondialdehyde determination in human plasma by high-performance liquid chromatography
Anal. Biochem.
Free malonaldehyde determination in tissues by high-performance liquid chromatography
Anal. Biochem.
Determination of malondialdehyde by ion-pairing high-performance liquid chromatography
Anal. Biochem.
A simple fluorometric assay for lipoperoxide involved in blood plasma
Biochem. Med.
Free radicals and lipid peroxidation in cell pathology
Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion
Can. J. Physiol. Pharmacol.
The eicosanoids and their biochemical mechanisms of action
Biochem. J.
Autoxidation of polyunsaturated fatty acids. II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides
Lipids
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
New Engl. J. Med.
Oxidative myocardial injury and cardiac-derived experimental systems
Oxygen radicals: their measurement in vivo
The thiobarbituric acid test for lipid peroxidation: structure of the adduct with malondialdehyde
Lipids
The intramolecular hydrogen bond in malonaldehyde
J. Am. Chem. Soc.
Conformational preferences in malondialdehyde and acetaldehyde enols investigated by nuclear magnetic resonance
J. Org. Chem.
Comparison of spectrophotometric and spectrofluorometric methods for the determination of malonaldehyde
Anal. Chem.
The acidity of malondialdehyde and the stability of its complexes with nickel (II) and copper (II)
Helv. Chim. Acta
Novel adducts from the modification of nucleic acid basis by malondialdehyde
J. Am. Chem. Soc.
Identification of adducts formed by reaction of guanine nucleosides with malondialdehyde and structurally related aldehydes
Chem. Res. Toxicol.
Contribution to the cyclization of hydrazones of α,β-unsaturated carbonyl compounds. The biscarbamyl- and bisthiocarbamylhydrazones of malondialdehyde
J. Org. Chem.
Cited by (0)
- 1
David R. Janero received his B.A. degree summa cum laude with biology honors from Boston University in 1976 and conducted his Ph.D. work at the Yale University School of Medicine in the Department of Cell Biology under Drs. R. Barnett and G.E. Palade. After completing his graduate work, Dr. Janero was appointed a National Institutes of Health Postdoctoral Fellow in the Department of Physiological Chemistry, Johns Hopkins University School of Medicine, under Dr. M.D. Lane's direction. In 1983, he joined Hoffman-La Roche Inc. as a Senior Scientist in the Department of Pharmacology and Chemotherapy and progressed to the rank of Research Investigator. Since 1989, Dr. Janero has been a member of the senior staff, Pharmaceuticals Division, of CIBA-GEIGY Corporation. The efforts of Dr. Janero and his research team are focused on increasing the mechanistic understanding of the pathogenesis of cardiovascular disease and satisfying associated medical needs through the discovery and development of novel therapeutics.